AddLife AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0014401378
SEK
152.00
-41 (-21.24%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Cantargia AB
Medicover AB
Ambea AB
BioArctic AB
AddLife AB
Intervacc AB
Q-linea AB
Hansa Biopharma AB
Xspray Pharma AB
Diamyd Medical AB
Ascelia Pharma AB

Why is AddLife AB ?

1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 17.75
2
Healthy long term growth as Net Sales has grown by an annual rate of 18.37% and Operating profit at 12.36%
3
The company has declared positive results for the last 2 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at SEK 1,162 MM
  • NET PROFIT(HY) At SEK 228.07 MM has Grown at 64.78%
  • INTEREST COVERAGE RATIO(Q) Highest at 725.93
4
With ROE of 6.69%, it has a expensive valuation with a 4.16 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -12.74%, its profits have risen by 66.6% ; the PEG ratio of the company is 0.9
5
Below par performance in long term as well as near term
  • Along with generating -12.74% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to AddLife AB should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is AddLife AB for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
AddLife AB
-100.0%
0.77
33.38%
OMX Stockholm 30
17.06%
0.95
17.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
18.37%
EBIT Growth (5y)
12.36%
EBIT to Interest (avg)
17.75
Debt to EBITDA (avg)
2.74
Net Debt to Equity (avg)
0.86
Sales to Capital Employed (avg)
0.96
Tax Ratio
34.80%
Dividend Payout Ratio
36.27%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.70%
ROE (avg)
13.77%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
4.16
EV to EBIT
34.47
EV to EBITDA
16.78
EV to Capital Employed
2.66
EV to Sales
2.56
PEG Ratio
0.94
Dividend Yield
0.40%
ROCE (Latest)
7.71%
ROE (Latest)
6.69%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 1,162 MM

NET PROFIT(HY)

At SEK 228.07 MM has Grown at 64.78%

INTEREST COVERAGE RATIO(Q)

Highest at 725.93

RAW MATERIAL COST(Y)

Fallen by -2.26% (YoY

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS

Here's what is working for AddLife AB

Operating Cash Flow
Highest at SEK 1,162 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Interest Coverage Ratio
Highest at 725.93
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Profit
At SEK 228.07 MM has Grown at 64.78%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (SEK MM)

Raw Material Cost
Fallen by -2.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales